Development of Clinical Weekly-Dose Teriparatide Acetate Encapsulated Dissolving Microneedle Patch for Efficient Treatment of Osteoporosis

Teriparatide acetate (TA), which directly promotes bone formation, is subcutaneously injected to treat osteoporosis. In this study, TA with a once-weekly administration regimen was loaded on dissolving microneedles (DMNs) to effectively deliver it to the systemic circulation via the transdermal rout...

Descripción completa

Detalles Bibliográficos
Autores principales: Sim, Jeeho, Kang, Geonwoo, Yang, Huisuk, Jang, Mingyu, Kim, Youseong, Ahn, Hyeri, Kim, Minkyung, Jung, Hyungil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571303/
https://www.ncbi.nlm.nih.gov/pubmed/36235975
http://dx.doi.org/10.3390/polym14194027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571303/
https://www.ncbi.nlm.nih.gov/pubmed/36235975
http://dx.doi.org/10.3390/polym14194027

Ejemplares similares